Basis: FMP quote market capitalization / four-quarter operating cash flow. Source: stored company filings and market data; unavailable inputs remain N/A.
The Price/OCF ratio is N/A as of 2026-10-06T17:47:44.390Z.
Calculation as of: 2026-10-06T17:47:44.390Z.
Quote observation: 2026-10-06T17:36:50.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 8dd4f1084baaf1fdd631c8004248db7003b46672aad8e0139030c30c223f55df
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PRICE/OCF RATIO
N/A
Market Cap
$16.89M
Price/OCF Ratio
N/A
TTM Avg
167.38
3Y Avg
1096.16
5Y Avg
872.23
Market Cap
$17.86M
Price/OCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$16.40M
Price/OCF Ratio
N/A
TTM Avg
43.53
3Y Avg
44.24
5Y Avg
48.21
| NAME | MARKET CAP | PRICE/OCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| PAVmed Inc. (PAVM) | $17.27M | N/A | N/A | N/A | N/A |
| Marker Therapeutics, Inc. (MRKR)vs › | $16.84M | N/A | N/A | N/A | N/A |
| Lipocine Inc. (LPCN)vs › | $17.07M | N/A | N/A | N/A | N/A |
| Cosmos Health Inc. (COSM)vs › | $17.51M | N/A | 14.35 | 40.20 | 40.20 |
| Palatin Technologies, Inc. (PTN)vs › | $16.89M | N/A | 167.38 | 1096.16 | 872.23 |
| Bionano Genomics, Inc. (BNGO)vs › | $16.70M | N/A | N/A | N/A | N/A |
| Estrella Immunopharma, Inc. (ESLA)vs › | $17.86M | N/A | N/A | N/A | N/A |
| Dyadic International, Inc. (DYAI)vs › | $16.40M | N/A | 43.53 | 44.24 | 48.21 |
| TScan Therapeutics, Inc. (TCRX)vs › | $16.18M | N/A | N/A | N/A | N/A |
| BioCardia, Inc. (BCDA)vs › | $15.78M | N/A | 64.40 | 51.01 | 44.81 |
P/OCF Ratio
N/A
P/FCF Ratio
N/A
P/OCF measures market price relative to operating cash flow: market cap divided by TTM operating cash flow. OCF is cash from operations before capital expenditures, so it sits above free cash flow — P/OCF typically reads below P/FCF, with the widest gap for capex-heavy businesses.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
